PPARG and type 2 diabetes mellitus: Although the use of TZDs has strongly declined due to their side effects, PPARg remains a promising target in the prevention and treatment of type 2 diabetes as highlighted by ongoing basic and clinical research (Ahmadian et al, 2013; Soccio et al, 2014; Banks et al, 2015; Chatterjee et al, 2017).